par
Thomas Dworetzky, Contributing Reporter | April 05, 2017
The combined efforts will also expand and enhance R&D capabilities.
As an example of such research advances, Canon noted that it has proprietary high-speed dynamic X-ray imaging sensor technology, among other imaging devices, along with associated elemental technologies; photoacoustic tomography technology selected by Japan’s national ImPACT program; medical robotic system technologies, and minimally-invasive technologies.
Ad Statistics
Times Displayed: 1227
Times Visited: 6 Fast-moving cardiac structures have a big impact on imaging. Fujifilm’s SCENARIA View premium performance CT brings solutions to address motion in Coronary CTA while delivering unique dose saving and workflow increasing benefits.
The technologies, combined with Toshiba Medical’s R&D capabilities, will let Canon “globally provide innovative new products and services in the future,” it stated.
Canon has forecast full-year operating profit to rise 11.4 percent, helped by Toshiba Medical's earnings. That's the first rise in the last three years, according to
a report in The Star Online.
The acquisition of Toshiba Medical Systems is part of Phase V of Canon's Excellent Global Corporation Plan, a five-year initiative launched in 2016.
“Canon aims to embrace the challenge of new growth through a grand strategic transformation,” it said in a statement in February concerning its Toshiba acquisition. One of the most important parts of its strategy, it stressed, was “to cultivate its health care business.”
Back to HCB News
